KANSL2 and glioblastoma: MiR-21-5p-inhbitor and si-KANSL2 was co-transfected into Rop-treated U87, U373, and U251 cells to figure out whether the miR-21-5p/KANSL2 axis was the crucial target for Rop-repressing GBM growth.